Berlin

Germany

1,792 total trials 717 recruiting

Filter these 1,792 trials by phase, condition, sponsor and more.

Open in Search →

A study to see how safe and effective the drug Luveltamab Tazevibulin (STRO-002) is in treating infants and children under 12 years old with … Ended

2023-506240-16-00 9 Acute Myeloid Leukemia (AML)
Molecular effects of deucravacitinib on plaque psoriasis and hard-to-treat psoriasis sites. Ended

2023-508948-22-00 6 moderate to severe plaque psoriasis
A clinical study comparing different doses of a potential new medicine with an inactive medicine for patients with moderate to severe psoria … Ended

2023-508992-35-00 4 Plaque Psoriasis
Phase 3 Study of Tamibarotene Plus Azacitidine in Patients Selected for RARA-positive Higher-risk MDS (SELECT-MDS-1) Ended

2023-510361-97-00 5 Newly Diagnosed RARA-positive Adult Patients with Higher-risk Myelodys
Immunological and functional characteristics of T memory-like cells in psoriasis under treatment with deucravacitinib. Ended

2024-510759-37-00 6 Plaque Psoriasis
Proof of concept study to assess the efficacy and safety of Danicopan (factor D inhibitor) in adult patients with chronic spontaneous urtica … Ended

2024-512386-14-00 4 Chronic spontaneous urticaria
A study to investigate the efficacy and safety of luveltamab tazevibulin versus IC chemotherapy in women with ovarian cancer (including fall … Ended

2024-512477-27-00 4 Advanced Epithelial Ovarian Cancer (including Fallopian Tube or Primar
CHRONOS - A study to learn about the effects and safety of ODM-111 in participants with long-lasting pain due to osteoarthritis of the knee. Ended

2024-513553-79-00 4 Chronic Pain due to Ostheoarthritis of the knee
CHRONDI Ended

2024-513595-17-00 4 CHRONIC PAIN DUE TO DIABETIC PERIPHERAL NEUROPATHY
Study on Pharmacokinetics of newly developed ANtiretroviral agents in HIV-infected pregNAnt women (PANNA) Ended

2024-515487-31-00 6 HIV-infected
DCC-3084 monotherapy in patients with solid tumors Ended

2024-517829-12-00 7 Solid tumors driven by the MAPK Pathway
Dose-ranging study evaluating the efficacy and safety of EVO756 in adults with Chronic Spontaneous Urticaria. Ended

2024-518786-10-01 4 Moderate to Severe Chronic Spontaneous Urticaria
COMPRENDO - A PHASE II OPEN LABEL STUDY FOR THE COMPREHENSIVE ANALYSIS OF PREDICTORS OF THE TREATMENT WITH PEMBROLIZUMAB AND OLAPARIB IN PAT … Ended

2024-519350-37-00 4 patients with unresectable or metastatic HER2 negative breast cancer a
A trial to learn if itraconazole and carbamazepine affect how AZD5462 moves throughout the bodies of healthy adults Ended

2024-519834-21-00 3 Chronic Heart Failure
Study of the Effectiveness and Safety of Acasunlimab Alone or With Pembrolizumab in treating Advanced Melanoma of the Skin That Has Returned … Ended

2025-520468-16-00 4 Cutaneous Melanoma, Relapsed/Refractory, Locally Advanced Unresectable
A study of lifileucel (tumor-infiltrating lymphocytes) in adults with advanced melanoma Ended

2025-522054-40-00 4 Previously treated advanced melanoma

Showing 1,777–1,792 of 1,792 trials